KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Equity Ratio: 2017-2024

Historic Equity Ratio for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to -0.03.

  • Amneal Pharmaceuticals' Equity Ratio fell 12.98% to -0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03, marking a year-over-year decrease of 12.98%. This contributed to the annual value of -0.03 for FY2024, which is 642.75% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Equity Ratio of -0.03 as of FY2024, which was down 642.75% from 0.01 recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Equity Ratio ranged from a high of 0.09 in FY2021 and a low of -0.03 during FY2024.
  • For the 3-year period, Amneal Pharmaceuticals' Equity Ratio averaged around 0.01, with its median value being 0.01 (2023).
  • In the last 5 years, Amneal Pharmaceuticals' Equity Ratio rose by 8.18% in 2021 and then slumped by 642.75% in 2024.
  • Amneal Pharmaceuticals' Equity Ratio (Yearly) stood at 0.09 in 2020, then climbed by 8.18% to 0.09 in 2021, then crashed by 48.01% to 0.05 in 2022, then tumbled by 88.10% to 0.01 in 2023, then plummeted by 642.75% to -0.03 in 2024.